Enterotype-specific microbial biomarkers of immune checkpoint inhibitor response revealed by large-scale integrated metagenomic analysis
Cancer Immunology, Immunotherapy · 26.05.2026 · 75 (8)
DOI: 10.1007/s00262-026-04432-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 26.05.2026. Verfasst von Francesco Candeliere und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125, Modena, Italy. Hauptthemen laut MEDLINE: Metagenomics, Immune Checkpoint Inhibitors, Gastrointestinal Microbiome, Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU, Università degli Studi di Modena e Reggio Emilia.
Abstract (Originalsprache)
The gut microbiota appears to play a critical role in modulating antitumor immune responses and influencing the efficacy of cancer immunotherapy drugs such as immune checkpoint inhibitors. However, the identification of consistent microbial biomarkers of response remains a significant challenge. This lack of consensus is largely driven by multi-source heterogeneity, including geographic variations in lifestyle, and high inter-individual variability. We hypothesize that these inconsistencies arise because microbiome composition is not uniform but organized into distinct enterotypes. To address this, we performed an integrated metagenomic analysis of 569 fecal samples from oncological patients affected by different tumor types treated with immunotherapy. The samples were clustered into two main enterotypes, E1 and E2, each of them containing two subclusters. A total of 166 species (e.g., Collinsella spp., Blautia spp., Bacteroides spp.) were identified as enterotype-specific biomarkers. A preliminary independent concordance assessment of these biomarkers was conducted in 19 oncologic patients with exceptional response to immunotherapy, providing an initial confirmation of selected enterotype-associated signals. Furthermore, we evaluated the predictive potential of gut microbiota profiles for immunotherapy outcomes through machine learning techniques. The models showed encouraging, albeit moderate, performance in the heterogeneous full dataset, supporting the potential of microbiome-based stratification as an exploratory framework for patient classification, while indicating that further validation is needed before clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125, Modena, Italy.
- Operative Unit of Oncology, Department of Oncology, ASST Cremona Hospital of Cremona, 26100, Cremona, Italy.
- Department of Physics, Informatics and Mathematics, University of Modena and Reggio Emilia, Modena, Italy.
- Division of Oncology, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Largo del Pozzo 71, Modena, Italy.
- Division of Oncology, Department of Oncology and Hematology, University of Modena and Reggio Emilia and University Hospital of Modena, Modena, Italy.
- Biogest-Siteia, University of Modena and Reggio Emilia, Modena, Italy.
ORCID-Profile: Massimo Dominici, Maddalena Rossi
Förderung
- NextGenerationEU
- Università degli Studi di Modena e Reggio Emilia
Zitieren
APA
Candeliere, F., Busi, E., Cerri, S., Sola, L., Lombardi, M., Greco, S., Pedroni, S., Amaretti, A., Raimondi, S., Chiavelli, C., Vitale, M. G., Bertolini, F., Depenni, R., Franchini, G., Dominici, M., & Rossi, M. (2026). Enterotype-specific microbial biomarkers of immune checkpoint inhibitor response revealed by large-scale integrated metagenomic analysis. Cancer Immunology, Immunotherapy, 75(8). https://doi.org/10.1007/s00262-026-04432-w
Vancouver
Candeliere F, Busi E, Cerri S, Sola L, Lombardi M, Greco S, et al. Enterotype-specific microbial biomarkers of immune checkpoint inhibitor response revealed by large-scale integrated metagenomic analysis. Cancer Immunology, Immunotherapy. 2026;75(8). doi:10.1007/s00262-026-04432-w
BibTeX
@article{Candeliere2026,
author = {Candeliere, Francesco and Busi, Enrico and Cerri, Sara and Sola, Laura and Lombardi, Matteo and Greco, Stefano and Pedroni, Sara and Amaretti, Alberto and Raimondi, Stefano and Chiavelli, Chiara and Vitale, Maria Giuseppa and Bertolini, Federica and Depenni, Roberta and Franchini, Giorgia and Dominici, Massimo and Rossi, Maddalena},
title = {Enterotype-specific microbial biomarkers of immune checkpoint inhibitor response revealed by large-scale integrated metagenomic analysis},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {8},
doi = {10.1007/s00262-026-04432-w}
}
EUVIMED